Why the study?
Right ventricular dysfunction is a major prognostic determinant in pulmonary embolism, and the study aimed to evaluate echocardiographic RV function in intermediate-high-risk patients, focusing on the effect of thrombolytic therapy.
Does thrombolytic therapy improve right ventricular free wall longitudinal strain in patients with intermediate-high-risk pulmonary embolism?
Does thrombolytic therapy improve right ventricular free wall longitudinal strain in patients with intermediate-high-risk pulmonary embolism?
In patients with intermediate-high-risk pulmonary embolism, thrombolytic therapy was associated with significantly better right ventricular systolic function as measured by echocardiographic longitudinal strain.
Answers are grounded in this paper and cite their sources.
Thrombolytic therapy was associated with better RVFWLS in intermediate-high-risk PE; hypothesis-generating and requires randomized confirmation before practice change.
Background and Aim: Pulmonary embolism (PE) is a cardiovascular disease associated with significant morbidity and mortality.Right ventricular (RV) dysfunction is a major determinant of prognosis in PE, and echocardiography is a key tool for assessing RV function.This study aimed to evaluate RV function by echocardiography in patients with intermediate-high-risk PE, with particular attention to the effect of thrombolytic therapy (TT). Materials and Methods:This retrospective, observational, comparative cohort study included 36 patients diagnosed with intermediate-high-risk PE between 2017 and 2019.The diagnosis of PE was confirmed by computed tomographic angiography or ventilation-perfusion scintigraphy.Echocardiographic assessment included RV free wall longitudinal strain (RVFWLS), and functional capacity was measured by the 6-minute walk distance (6MWD).Patients were divided into TT and non-TT groups for comparison. Results:Of 36 patients diagnosed with intermediate-high-risk PE, 58.3% (n=21) received TT, while 41.7% (n=15) did not receive this treatment.The mean RVFWLS was -29.76% in the TT group and -22.8% in the non-TT group (P = 0.012).The mean 6MWD was 434 m in the group receiving TT and 357 m in the group not receiving TT.Although 6MWD was higher in the TT group, the difference was not statistically significant (P = 0.179). Conclusion:Echocardiographic evaluation provides valuable insight into RV function in patients with PE.In this cohort of intermediate-highrisk patients, TT was associated with better preservation of RV systolic function, supporting its potential role in selected cases.
No takes yet. Share an insight, caveat, or question.
Avcı et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: